ENTITY
HitGen

HitGen (688222 CH)

5
Analysis
Health CareChina
HitGen Inc. offers generic pharma services. The Company provides deoxyribonucleic acid encoded libraries (DEL) rating, DEL selecting, chemical synthesis, and other services. HitGen provides its services throughout China.
more
02 Jun 2021 09:31

Pre-IPO Shanghai Haoyuan Chemexpress - A New CRO/CDMO with Continued High Growth Potential

As CRO/CDMO continues to be a hot sector for investors and have outstanding performance, the new pre-IPO company Haoyuan Chemexpress with high...

Logo
204 Views
Share
bullishNinebot
21 Apr 2021 09:59

STAR Board - STAR50 Index Rebalance June Preview: Falling Volumes Increasing Impact

We see 5 changes to the STAR50 Index at the June review. The deletions are high probability, but there is uncertainty on the inclusions due to a...

Logo
419 Views
Share
bullishNinebot
09 Mar 2021 05:36

STAR50 Index Rebalance June Preview: Selloff Presents Opportunity

While the deletions at the STAR50 June review can be picked fairly easily, index rules that are not specific give rise to two sets of potential...

Logo
349 Views
Share
No more insights
x